Current understanding and management of chronic hepatosplenic suppurative brucellosis

被引:78
作者
Ariza, J
Pigrau, C
Cañas, C
Marrón, A
Martínez, F
Almirante, B
Corredoira, JM
Casanova, A
Fabregat, J
Pahissa, A
机构
[1] Univ Barcelona, Bellvitge Hosp, Infect Dis Serv, Barcelona 08907, Spain
[2] Univ Barcelona, Bellvitge Hosp, Dept Radiol, Barcelona 08907, Spain
[3] Univ Barcelona, Bellvitge Hosp, Microbiol Serv, Barcelona 08907, Spain
[4] Univ Barcelona, Bellvitge Hosp, Dept Surg, Barcelona 08907, Spain
[5] Hosp Gen Valle Hebron, Infect Dis Serv, Barcelona, Spain
关键词
D O I
10.1086/319608
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To outline the characteristics and define appropriate management of chronic hepatosplenic suppurative brucellosis (CHSB), 905 patients with brucellosis were analyzed. Sixteen episodes of CHSB (14 in the liver and 2 in the spleen) were found in 15 patients. Six patients had had previous remote brucellosis. Twelve patients presented with systemic symptoms, and 12 with local symptoms. Cultures of blood samples yielded negative results in all cases except 1, and the results of cultures of pus specimens were positive for Brucella melitensis in only 2 cases. All patients showed calcium deposits surrounded by a hypodense area on computed tomography. Patients often had low titers of agglutinating antibody. In patients who were receiving conservative management, early response was successful in 50% and late response was successful in 33.3%. In the patients who underwent surgery and concomitant antibiotic therapy, early and late response was successful in 100%. Thus, CHSB mainly represents a local reactivation of previous brucellosis. Its diagnosis may be difficult to establish and surgery may be required to cure many patients.
引用
收藏
页码:1024 / 1033
页数:10
相关论文
共 61 条
  • [1] ALTON G. G., 1988, TECHNIQUES BRUCELLOS
  • [2] UNIQUE TYPE OF CALCIFICATION IN CHRONIC BRUCELLOSIS
    ARCOMANO, JP
    PIZZOLATO, NF
    SINGER, R
    ZUCKER, SM
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 1977, 128 (01) : 135 - 137
  • [3] ARIZA J, 1985, REV INFECT DIS, V7, P656
  • [4] SPECIFIC ANTIBODY PROFILE IN HUMAN BRUCELLOSIS
    ARIZA, J
    PELLICER, T
    PALLARES, R
    FOZ, A
    GUDIOL, F
    [J]. CLINICAL INFECTIOUS DISEASES, 1992, 14 (01) : 131 - 140
  • [5] CHARACTERISTICS OF AND RISK-FACTORS FOR RELAPSE OF BRUCELLOSIS IN HUMANS
    ARIZA, J
    CORREDOIRA, J
    PALLARES, R
    VILADRICH, PF
    RUFI, G
    PUJOL, M
    GUDIOL, F
    [J]. CLINICAL INFECTIOUS DISEASES, 1995, 20 (05) : 1241 - 1249
  • [6] TREATMENT OF HUMAN BRUCELLOSIS WITH DOXYCYCLINE PLUS RIFAMPIN OR DOXYCYCLINE PLUS STREPTOMYCIN - A RANDOMIZED, DOUBLE-BLIND-STUDY
    ARIZA, J
    GUDIOL, F
    PALLARES, R
    VILADRICH, PF
    RUFI, G
    CORREDOIRA, J
    MIRAVITLLES, MR
    [J]. ANNALS OF INTERNAL MEDICINE, 1992, 117 (01) : 25 - 30
  • [7] BRUCELLA-MELITENSIS SPLENIC ABSCESS - SONOGRAPHIC DETECTION AND FOLLOW-UP
    ATES, KB
    DOLAR, ME
    KARAHAN, M
    TEMUCIN, G
    ONARAN, L
    [J]. JOURNAL OF CLINICAL ULTRASOUND, 1992, 20 (05) : 349 - 351
  • [8] Banos Madrid R, 1999, Gastroenterol Hepatol, V22, P162
  • [9] Bastin R, 1973, Med Chir Dig, V2, P199
  • [10] BOIREAU JP, 1983, THESIS PARIS